Following the virtual presentation of Phase 1b data on candidate
NKTR-358 in systemic lupus erythematosus patients at EULAR 2020, Nektar
Therapeutics (NASDAQ:NKTR) will host a webcast and conference call on Friday, June 5, at 11:00 am ET to discuss the results.
https://seekingalpha.com/news/3578830-nektar-therapeutics-to-host-webcast-on-nktrminus-358-data-june-5
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.